Predictors of Transition to Adult Rheumatology Care Explored
FRIDAY, Sept. 11, 2020 -- For pediatric patients transferring to an adult rheumatology clinic, continued insurance coverage and referral from a pediatric rheumatologist predict shorter time to completed adult visit, according to a study published online Sept. 9 in Arthritis Care & Research.
Nicole Bitencourt, M.D., from the University of Texas Southwestern Medical Center in Dallas, and colleagues conducted a retrospective analysis of pediatric patients transferring to an adult rheumatology clinic to quantify the time between final pediatric and first adult visits and to assess health care utilization. Data were included for 141 pediatric patients who transferred care.
The researchers found that there was a mean of 221 days between final pediatric and first completed adult rheumatology visit. Continued insurance coverage, younger age at referral, and referral from a pediatric rheumatologist were predictive of shorter time to completed adult visit in regression modeling. Connective tissue disease (CTD) diagnosis and Black race were factors associated with hospitalizations (odds ratios, 8.54 and 3.04, respectively) and emergency department visits (odds ratios, 3.6 and 6.0, respectively). Fifteen percent of patients with CTD had end-stage renal disease or death.
"It may be helpful for pediatric rheumatologists to have a system in place to ensure patients are not lost to follow up before establishing care with an adult rheumatologist," Bitencourt said in a statement.
© 2020 HealthDay. All rights reserved.
Posted: September 2020
Read this next
MONDAY, Sept. 14, 2020 -- Adherence to a Mediterranean diet (MedD) is associated with the risk for rheumatoid arthritis (RA) among ever-smoking women, but not among women in general,...
WEDNESDAY, Sept. 9, 2020 -- Disease-modifying antirheumatic drug (DMARD) therapy for rheumatoid arthritis (RA) treatment also cuts cardiovascular disease (CVD) risk, according to a...
FRIDAY, Aug. 28, 2020 -- Respiratory diseases increase the risk for rheumatoid arthritis, according to a study published online Aug. 16 in Arthritis & Rheumatology. Vanessa L....
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.